When do you consider employing the 4-week dosing schedule for nivolumab?  

The FDA has approved the new dosing schedule of Nivolumab 480 mg every 4 weeks for multiple disease sites (melanoma, RCC, urothelial carcinoma, SCC of the head and neck, HCC). Are there specific scenarios where you feel necessary to maintain the 2 week schedule?



Answer from: Medical Oncologist at Community Practice
Comments
Medical Oncologist at Virginia Cancer Inst
I agree fully - one of my patients who has been on...
Medical Oncologist at NYU Winthrop Hospital
I start Q 2 week, if they tolerate it well, after ...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Hartford Hospital
Thanks for all this helpful information. Some pts...
Sign in or Register to read more

Answer from: Medical Oncologist at Community Practice

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Wenatchee Valley Med Center
Thank you, @Jade Homsi. Do you have concerns about...
Medical Oncologist at University of Texas Southwestern
I believe so for now. I think that the 4 week sche...
Medical Oncologist at Hartford Hospital
I am beginning to see harsher toxicities while usi...
Medical Oncologist at Wenatchee Valley Med Center
@Omar Eton- that is the experience that I am havin...
Sign in or Register to read more